US Patent 10946023 Therapeutically active compounds and their methods of use
Patent 10946023 was granted and assigned to Agios Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+178 characters)
Article
Patent abstract
Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109460230
Date of Patent
March 16, 2021
0Patent Application Number
161677250
Date Filed
October 23, 2018
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 23 Mar, 2023
Golden AI
Infobox
Golden AI
Edits on 28 Sep, 2022
Golden AI
Infobox
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109460230
Date of Patent
March 16, 2021
0Patent Application Number
161677250
Date Filed
October 23, 2018
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Feb, 2022
Golden AI
Edits made to:
Infobox (+13 properties)
US Patent 10946023 Therapeutically active compounds and their methods of use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10946023
Date of patent
March 16, 2021
Patent application number
16167725
Date Filed
October 23, 2018
Patent citations
Patent primary examiner
Find more entities like US Patent 10946023 Therapeutically active compounds and their methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
